Jentashapir Journal of Health Research

Published by: Kowsar

Protective or Deteriorative Effect of Zinc Ions on Protein Misfolding: A New Insight into Amyloidogenic Disease

Sepideh Noorzadeh 1 , Mohammad Reza Dayer 2 , * and Saeed Aminzadeh 3
Authors Information
1 Nourdanesh Institute of Higher Education of Meymeh, Esfahan, IR Iran
2 Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, IR Iran
3 National Institute of Genetic Engineering and Biotechnology, Shahrak-e Pajoohesh, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: August 2017, 8 (4); e64461
  • Published Online: August 20, 2017
  • Article Type: Research Article
  • Received: March 15, 2017
  • Revised: September 26, 2017
  • Accepted: October 10, 2017
  • DOI: 10.5812/jjhr.64461

To Cite: Noorzadeh S, Dayer M R, Aminzadeh S. Protective or Deteriorative Effect of Zinc Ions on Protein Misfolding: A New Insight into Amyloidogenic Disease, Jentashapir J Health Res. 2017 ;8(4):e64461. doi: 10.5812/jjhr.64461.

Abstract
Copyright © 2017, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI. Alzheimer's disease, beta-amyloid protein and zinc. J Nutr. 2000;130(5S Suppl):1488S-92S. [PubMed: 10801964].
  • 2. Liu R, Su R, Qi W, He Z. Photo-induced inhibition of insulin amyloid fibrillation on online laser measurement. Biochem Biophys Res Commun. 2011;409(2):229-34. doi: 10.1016/j.bbrc.2011.04.132. [PubMed: 21570949].
  • 3. Bekard IB, Dunstan DE. Tyrosine autofluorescence as a measure of bovine insulin fibrillation. Biophys J. 2009;97(9):2521-31. doi: 10.1016/j.bpj.2009.07.064. [PubMed: 19883595]. [PubMed Central: PMC2770625].
  • 4. Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M. Effect of zinc binding on beta-amyloid structure and dynamics: implications for Abeta aggregation. Biophys J. 2011;101(5):1202-11. doi: 10.1016/j.bpj.2011.06.062. [PubMed: 21889458]. [PubMed Central: PMC3164126].
  • 5. Faller P, Hureau C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans. 2009;(7):1080-94. doi: 10.1039/b813398k. [PubMed: 19322475].
  • 6. Hane F, Leonenko Z. Effect of metals on kinetic pathways of amyloid-beta aggregation. Biomolecules. 2014;4(1):101-16. doi: 10.3390/biom4010101. [PubMed: 24970207]. [PubMed Central: PMC4030978].
  • 7. Tougu V, Tiiman A, Palumaa P. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. Metallomics. 2011;3(3):250-61. doi: 10.1039/c0mt00073f. [PubMed: 21359283].
  • 8. Hua QX, Weiss MA. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem. 2004;279(20):21449-60. doi: 10.1074/jbc.M314141200. [PubMed: 14988398].
  • 9. Bouchard M, Zurdo J, Nettleton EJ, Dobson CM, Robinson CV. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 2000;9(10):1960-7. doi: 10.1110/ps.9.10.1960. [PubMed: 11106169]. [PubMed Central: PMC2144465].
  • 10. Whittingham JL, Scott DJ, Chance K, Wilson A, Finch J, Brange J, et al. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. J Mol Biol. 2002;318(2):479-90. doi: 10.1016/S0022-2836(02)00021-9. [PubMed: 12051853].
  • 11. Nettleton EJ, Tito P, Sunde M, Bouchard M, Dobson CM, Robinson CV. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys J. 2000;79(2):1053-65. doi: 10.1016/S0006-3495(00)76359-4. [PubMed: 10920035]. [PubMed Central: PMC1301001].
  • 12. Dong J, Wan Z, Popov M, Carey PR, Weiss MA. Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrils. J Mol Biol. 2003;330(2):431-42. [PubMed: 12823980].
  • 13. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL. Partially folded intermediates in insulin fibrillation. Biochemistry. 2003;42(39):11404-16. doi: 10.1021/bi034868o. [PubMed: 14516191].
  • 14. Parodi J, Ormeno D, Ochoa-de la Paz LD. Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer's disease study. BMB Rep. 2015;48(1):13-8. [PubMed: 25047445]. [PubMed Central: PMC4345636].
  • 15. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008;37(5):505-12. doi: 10.1093/ageing/afn095. [PubMed: 18487267].
  • 16. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris). 1997;153(3):185-92. [PubMed: 9296132].
  • 17. Goda S, Takano K, Yamagata Y, Nagata R, Akutsu H, Maki S, et al. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Sci. 2000;9(2):369-75. doi: 10.1110/ps.9.2.369. [PubMed: 10716189]. [PubMed Central: PMC2144556].
  • 18. Prasad AS. Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol. 2012;26(2-3):66-9. doi: 10.1016/j.jtemb.2012.04.004. [PubMed: 22664333].
  • 19. Walker BR, Colledge NR. Davidson's Principles and Practice of Medicine E-Book. Elsevier Health Sciences; 2013.
  • 20. Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol. 2013;19(5):665-72. doi: 10.3748/wjg.v19.i5.665. [PubMed: 23429751]. [PubMed Central: PMC3574592].
  • 21. Foster M, Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients. 2012;4(7):676-94. doi: 10.3390/nu4070676. [PubMed: 22852057]. [PubMed Central: PMC3407988].
  • 22. Suzuki H, Asakawa A, Li JB, Tsai M, Amitani H, Ohinata K, et al. Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric. 2011;3(3):226-31. [PubMed: 21846317].
  • 23. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012;86(4):521-34. doi: 10.1007/s00204-011-0775-1. [PubMed: 22071549].
  • 24. Millichap JG, Yee MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics. 2012;129(2):330-7. doi: 10.1542/peds.2011-2199. [PubMed: 22232312].
  • 25. Bush AI, Tanzi RE. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics. 2008;5(3):421-32. doi: 10.1016/j.nurt.2008.05.001. [PubMed: 18625454]. [PubMed Central: PMC2518205].
  • 26. Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA. Role of metal dyshomeostasis in Alzheimer's disease. Metallomics. 2011;3(3):267-70. doi: 10.1039/c0mt00074d. [PubMed: 21298161]. [PubMed Central: PMC3117398].
  • 27. Ha C, Ryu J, Park CB. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Biochemistry. 2007;46(20):6118-25. doi: 10.1021/bi7000032. [PubMed: 17455909].
  • 28. Pedersen JT, Ostergaard J, Rozlosnik N, Gammelgaard B, Heegaard NH. Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-beta peptides. J Biol Chem. 2011;286(30):26952-63. doi: 10.1074/jbc.M111.220863. [PubMed: 21642429]. [PubMed Central: PMC3143654].
  • 29. Sarell CJ, Wilkinson SR, Viles JH. Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-{beta} from Alzheimer disease. J Biol Chem. 2010;285(53):41533-40. doi: 10.1074/jbc.M110.171355. [PubMed: 20974842]. [PubMed Central: PMC3009880].
  • 30. Danielsson J, Pierattelli R, Banci L, Graslund A. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. FEBS J. 2007;274(1):46-59. doi: 10.1111/j.1742-4658.2006.05563.x. [PubMed: 17222176].
  • 31. Cardoso SM, Rego AC, Pereira C, Oliveira CR. Protective effect of zinc on amyloid-beta 25-35 and 1-40 mediated toxicity. Neurotox Res. 2005;7(4):273-81. [PubMed: 16179264].
  • 32. Brange J, Owens DR, Kang S, Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 1990;13(9):923-54. [PubMed: 2226110].
  • 33. Baker EN, Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, et al. The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci. 1988;319(1195):369-456. [PubMed: 2905485].
  • 34. De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays. 2004;26(12):1351-62. doi: 10.1002/bies.20151. [PubMed: 15551269].
  • 35. Attri AK, Fernandez C, Minton AP. pH-dependent self-association of zinc-free insulin characterized by concentration-gradient static light scattering. Biophys Chem. 2010;148(1-3):28-33. doi: 10.1016/j.bpc.2010.02.002. [PubMed: 20202737]. [PubMed Central: PMC2856799].
  • 36. Dunn MF. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review. Biometals. 2005;18(4):295-303. doi: 10.1007/s10534-005-3685-y. [PubMed: 16158220].
  • 37. Correia M, Neves-Petersen MT, Jeppesen PB, Gregersen S, Petersen SB. UV-light exposure of insulin: pharmaceutical implications upon covalent insulin dityrosine dimerization and disulphide bond photolysis. PLoS One. 2012;7(12). e50733. doi: 10.1371/journal.pone.0050733. [PubMed: 23227203]. [PubMed Central: PMC3515625].
  • 38. Nedumpully-Govindan P, Yang Y, Andorfer R, Cao W, Ding F. Promotion or Inhibition of Islet Amyloid Polypeptide Aggregation by Zinc Coordination Depends on Its Relative Concentration. Biochemistry. 2015;54(50):7335-44. doi: 10.1021/acs.biochem.5b00891. [PubMed: 26603575].
  • 39. Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009;58(9):2070-83. doi: 10.2337/db09-0551. [PubMed: 19542200]. [PubMed Central: PMC2731533].
  • 40. Brender JR, Hartman K, Nanga RP, Popovych N, de la Salud Bea R, Vivekanandan S, et al. Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc. 2010;132(26):8973-83. doi: 10.1021/ja1007867. [PubMed: 20536124]. [PubMed Central: PMC2904811].
  • 41. Salamekh S, Brender JR, Hyung SJ, Nanga RP, Vivekanandan S, Ruotolo BT, et al. A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc. J Mol Biol. 2011;410(2):294-306. doi: 10.1016/j.jmb.2011.05.015. [PubMed: 21616080]. [PubMed Central: PMC3115507].
  • 42. Tougu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, et al. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J Neurochem. 2009;110(6):1784-95. doi: 10.1111/j.1471-4159.2009.06269.x. [PubMed: 19619132].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments